← Open Payments lookup

CHRISTINA ALANIS: Open Payments

NPI 1851045736 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,692 in 66 payments from 20 companies in 2025. Trend: 2023 $2,782 · 2024 $1,549 · 2025 $1,692

Food & beverage: $1,692
CompanyPaymentsAmount
Alnylam Pharmaceuticals Inc.9$365
Novartis Pharmaceuticals Corporation16$337
Amgen Inc.6$200
Kestra Medical Technology Services, Inc.3$112
Merck Sharp & Dohme LLC5$86
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)3$78
Novo Nordisk Inc3$64
Actelion Pharmaceuticals US, Inc.2$61
E.R. Squibb & Sons, L.L.C.3$54
Bayer Healthcare Pharmaceuticals Inc.3$52

Products named: LEQVIO, AMVUTTRA, REPATHA, Assure WCD, VERQUVO, LifeVest, OPSUMIT, Kerendia.

Industry payments across TX — which companies pay providers there.